Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.

Saved in:
Bibliographic Details
Title: Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
Authors: Courtinard C; University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, 33000, Bordeaux, France.; Unicancer, 101 Rue de Tolbiac, 75654, Paris, France., Gourgou S; Biometrics Unit, Institut du Cancer de Montpellier, 208 Rue Des Apothicaires, 34298, Montpellier, France.; University of Montpellier, 163 Rue Auguste Broussonnet, 34090, Montpellier, France., Jacot W; University of Montpellier, 163 Rue Auguste Broussonnet, 34090, Montpellier, France.; Department of Medical Oncology, Institut du Cancer de Montpellier, 208 Rue Des Apothicaires, 34298, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM) INSERM U1194, 208 Rue Des Apothicaires, 34298, Montpellier, France., Carton M; Department of Biostatistics, Institut Curie, 35 Rue Dailly, 92210, Saint-Cloud, France., Guérin O; Department of Medical Information, Institut de Cancérologie de L'Ouest Nantes & Angers, 15 Rue André Boquel, 49055, Angers, France., Vacher L; Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011, Clermont Ferrand, France., Bertaut A; Department of Biometry, Institut de Cancérologie de Bourgogne, 21079, Dijon, France., Le Deley MC; Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France., Pérol D; Department of Biometry, Centre Léon Bérard, 28 Prom. Léa Et Napoléon Bullukian, Lyon, 69008, France., Marino P; Institut Paoli-Calmettes, SESSTIM UMR912, 232, Boulevard Sainte-Marguerite, 13009, Marseille, France.; Aix-Marseille Université, Inserm, IRD, SESSTIM Sciences Économiques Et Sociales de La Santé Et Traitement de L'information Médicale, 13009, Marseille, France., Levy C; Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000, Caen, France., Uwer L; Medical Oncology Department, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519, Vandœuvre-lès-Nancy, France., Perrocheau G; Department of Pharmacy, Institut de Cancérologie de L'Ouest Nantes, Bd Professeur Jacques Monod, 44800, Saint-Herblain, France., Schiappa R; Department of Biometry, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189, Nice, France., Bachelot F; Department of Medical Information, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France., Parent D; Department of Pharmacy, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100, Reims, France., Breton M; Department of Medical Information, Centre Eugène Marquis, Avenue de La Bataille Flandres-Dunkerque, 35000, Rennes, France., Petit T; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, 67200, Strasbourg, France., Filleron T; Department of Biometry, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059, Toulouse, France., Loeb A; Department of Medical Information, Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France., Mathoulin-Pélissier S; University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, 33000, Bordeaux, France.; Inserm CIC1401, Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, 33000, Bordeaux, France., Robain M; Unicancer, 101 Rue de Tolbiac, 75654, Paris, France., Delaloge S; Department of Cancer Medicine, Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94800, Villejuif, France., Bellera C; University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, 33000, Bordeaux, France. C.bellera@bordeaux.unicancer.fr.; Inserm CIC1401, Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, 33000, Bordeaux, France. C.bellera@bordeaux.unicancer.fr.
Source: BMC medicine [BMC Med] 2023 Mar 08; Vol. 21 (1), pp. 87. Date of Electronic Publication: 2023 Mar 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1741-7015
DOI:10.1186/s12916-023-02754-5